Phase III, Open, Multicenter and Randomized Study of Customized Adjuvant Chemotherapy Based on BRCA1 mRNA Levels in Completely Resected Stages II-IIIA Non-Small-Cell Lung Cancer Patients .
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Docetaxel; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms GECP-SCAT
- 07 Jul 2015 Biomarkers information updated
- 16 Mar 2012 Planned end date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 06 Jun 2011 Study design details presented at the 47th Annual Meeting of the American Society of Clinical Oncology.